Lifeforce Review

Lifeforce occupies the middle of the market. It costs more than the data-only biomarker platforms and far less than a concierge program, and the thing it buys with the difference is a clinician who can write a prescription. The panel is roughly 40 markers with expanded hormone coverage, run twice a year, with a nurse-practitioner review of every result included in the monthly fee.

That structure sets the whole review. A $499/yr platform measures more markers than Lifeforce and costs a third as much, and it stops at the report. Lifeforce measures fewer markers and continues into treatment. Whether that is worth roughly $1,900 a year depends entirely on whether you expect a result to change what you take. For someone whose testosterone, thyroid, or metabolic numbers are likely to warrant therapy, the bundled clinician is the product. For someone who wants a wide annual snapshot and nothing more, it is an expensive way to get fewer markers.

Scorecard

What you get for the money

Lifeforce sells one membership rather than a menu, which makes the boundary between included and extra unusually clean. Everything diagnostic and everything clinical is inside the fee. Everything you swallow or inject is outside it.

• Included — the panel, twice a year. Around 40 biomarkers with expanded hormone coverage, run on a semi-annual cadence. Both draws sit inside the membership.
• Included — the draw itself. Mobile phlebotomy in markets where it is offered, otherwise a partner lab appointment. Availability varies by market.
• Included — the clinician review. A nurse practitioner reads every panel and walks through it with you. This is the line item that separates Lifeforce from the data-only platforms.
• Included — ongoing telehealth access. Follow-up contact between panels, so a side effect or a question does not wait six months for the next report.
• Included — the coaching layer. Sleep, training, and nutrition guidance layered on top of the clinical relationship rather than replacing it.
• Not included — prescriptions. Hormone therapy, peptides, and GLP-1 medications are billed separately. On a GLP-1 this can exceed the membership fee several times over.
• Not included — Lifeforce's own supplements. They are offered, not required, and the membership works fine without them.
• Not included — imaging, specialist referrals, or anything in-person. The program is telehealth end to end.

What it costs

The first month is front-loaded because it carries the initial panel and the first consult. After that the number flattens. Two figures matter: the program cost, which is predictable, and the prescription cost, which is not.

The forecasting problem is the prescription line. A testosterone protocol and a compounded GLP-1 protocol are not in the same order of magnitude, and neither is quoted in the membership price. Before signing up, ask what the medication you are likely to be prescribed actually costs through Lifeforce's pharmacy partners, and compare that to a retail or insurance-covered price. For some medications the difference is trivial. For GLP-1s it can be the largest number in the whole plan.

Signing up and the first visit

Onboarding starts with an intake covering symptoms, medications, and goals, which determines whether any optional markers are added to the base panel. Blood collection is a full venous draw, not a finger-prick — the panel includes markers that capillary collection handles poorly. In markets with mobile phlebotomy the draw happens at home on a scheduled visit; elsewhere it is a partner lab appointment. Fasting is required, so the appointment is a morning one.

Results typically post within one to two weeks of the draw. The report groups markers by system — hormones, thyroid, metabolic, lipids, inflammation, nutrients — and shows each against both a standard reference range and an optimal range, which are not the same thing and frequently disagree. A marker can sit inside the lab's normal range and still be flagged as suboptimal, and that gap is where most of the consult conversation happens.

The clinician consult is scheduled after results post. It is a video visit with a nurse practitioner, and it covers the findings, the plan, and whether a prescription is warranted. Where a controlled substance is involved, state rules determine whether the visit must be synchronous. From order to completed consult, most people are looking at three to four weeks.

What the panel covers

Roughly 40 markers, weighted toward hormones and the systems that interact with them. The named groups:

• Sex hormones. Total and free testosterone, estradiol, SHBG, DHEA-S, and progesterone. The expanded coverage here is what makes the panel usable for women as well as men.
• Pituitary signalling. LH and FSH, which separate a gonadal cause of low hormone levels from a central one — a distinction that changes the treatment, not just the dose.
• Thyroid. TSH with free T3 and free T4. A TSH-only screen misses the pattern where TSH is normal and free T3 is low, which produces the same fatigue people usually blame on testosterone.
• Metabolic. Fasting glucose, HbA1c, and insulin. Fasting insulin is the one that moves first — it can be elevated for years while glucose and HbA1c stay unremarkable.
• Lipids. The standard panel plus ApoB where ordered. ApoB counts atherogenic particles rather than the cholesterol inside them, which is why it disagrees with LDL-C in roughly one in five people.
• Inflammation. hs-CRP, which is sensitive to a recent cold or a hard training block and should be re-run rather than acted on if it comes back isolated and high.
• Nutrients and organ function. Vitamin D, B12, ferritin, a CBC, and liver and kidney panels — the safety baseline any therapy decision needs.

Absent from the routine panel: Lp(a), which is genetically determined and only needs measuring once in a lifetime but changes cardiovascular risk stratification substantially when it is high, and the omega-3 index. Both can be ordered elsewhere for modest cost and are worth having once.

Strengths

• Clinician time is inside the membership fee rather than an add-on, so reading the panel and acting on it are the same purchase.
• Two panels a year is a real cadence. Annual testing shows you a number; semi-annual testing shows you a direction, which is what an intervention is judged on.
• The hormone coverage extends past testosterone to LH, FSH, SHBG, DHEA-S, and progesterone, which makes the panel diagnostically useful for women and not only for men on TRT.
• Thyroid is measured with free T3 and free T4 rather than TSH alone, catching a fatigue pattern that TSH-only screening routinely misses.
• The prescription pathway spans hormone therapy, peptides, and GLP-1 medications under one clinician, so a metabolic finding and a hormone finding do not require two providers.
• Pricing is a flat membership. Unlike a la carte programs, the cost of the diagnostic side does not climb every time the clinician wants another marker.

Trade-offs

• Around 40 markers is well under the 100+ that $499/yr platforms measure, so the panel is narrower than programs costing a third as much.
• Prescriptions are billed separately and are not quoted upfront, which makes the true annual cost unforecastable until you know what you will be prescribed.
• Care is nurse-practitioner-led by default. That is appropriate for routine optimization and thin for a complex case with several interacting conditions.
• Everything is telehealth. No physical exam, no in-person blood pressure, no imaging, and no specialist referral inside the program.
• Mobile phlebotomy availability varies by market. Where it is not offered, the convenience advantage over a standard lab platform mostly disappears.
• Semi-annual is too slow for active titration. Starting a hormone protocol needs a check at 6–12 weeks, which sits outside the standard cadence.

How it compares

The comparison set below is the mid-tier telehealth cluster: programs that combine lab work with a clinician who can prescribe. They are listed alphabetically, and the same six criteria are applied to every row.

Lifeforce is the broadest panel of the four and the only one that bundles the clinician consult into a flat monthly figure. Hone Health has the cheapest entry at ~$45 and the least friction, because the first test is a finger-prick done at home, but its panel stops at hormones and therapy safety markers. Marek Health goes deepest and costs the most, with a realistic year-one range of $2,500–$6,000+ driven by 8–12 week retesting during titration. Maximus is the only one of the four organized around an enclomiphene protocol, which preserves fertility rather than suppressing it. Read across the row that matches your actual question rather than the price column alone.

Who should buy it — and who should not

Buy it if:

• You expect a result to lead to treatment, and you want the person reading the panel to be the person who writes the prescription.
• You are a peri- or post-menopausal woman who wants hormone coverage and a prescribing clinician in one program.
• You want twice-yearly testing to judge whether an intervention is working, not a once-a-year snapshot.
• Your question spans hormones and metabolic health together, and you do not want to manage two separate providers.
• Predictable flat pricing on the diagnostic side matters more to you than maximum marker count.

Look elsewhere if:

• You want the widest possible panel for the money — buy Function Health or Superpower at $499/yr for 100+ markers.
• Hormones are your only question and cost is the constraint — Hone Health starts at ~$45 for the test.
• You want frequent deep retesting through a titration — Marek Health runs labs every 8–12 weeks and lets you choose the markers.
• Fertility preservation is a requirement — Maximus offers the enclomiphene protocol, which keeps LH and FSH intact.
• You want unlimited physician time and in-person care — compare the concierge tier under doctor-led options.

A named exception that changes the calculus: if you are on an SSRI, low libido and flat mood are common medication effects and are frequently misattributed to low testosterone. Treating the hormone in that situation often does not resolve the symptom. Raise the medication history in the consult before a protocol is designed around it. A second case: if ferritin is already above roughly 200 ng/mL, that finding deserves its own workup before any hormone therapy starts, because iron overload produces fatigue that no amount of testosterone corrects.

Retesting and what year two costs

The membership includes two panels a year, so retesting is a cadence rather than a purchase. The renewal buys the same thing the first year bought: two panels, the clinician relationship, telehealth access, and the coaching layer. It does not add markers, and it does not include prescriptions.

Twelve months at roughly $129 lands near $1,550 on the program side, which is about $220–$350 less than year one because the ~$349 entry month does not repeat. Prescriptions remain outside that figure. Someone on a hormone protocol should budget the medication as a separate recurring line and treat the membership as the diagnostic and clinical overhead sitting on top of it.

If you start a therapy, expect an interim check at 6–12 weeks that falls outside the semi-annual rhythm. Confirm whether that check is covered by the membership or ordered separately before you start — it is the single most common surprise on the bill, and it is a check worth having either way.

Related

• All doctor-led options compared
• Hone Health review
• Marek Health cost
• Maximus review
• Function Health alternatives
• Lifeforce cost breakdown
• Lifeforce alternatives — eight platforms compared
• Is Lifeforce worth it?
• Normal vs optimal ranges
• Best hormone therapy for women